
June 27 (Reuters) - Lyra Therapeutics Inc LYRA.O:
LYRA THERAPEUTICS ANNOUNCES UP TO APPROXIMATELY $15 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
LYRA THERAPEUTICS INC - COMBINED EFFECTIVE PURCHASE PRICE PER SHARE IS $11.81